Back to Search
Start Over
Favorable outcome of chronic myeloid leukemia co-expressing e13a2 and e14a2 transcripts, treated with nilotinib
- Publication Year :
- 2020
-
Abstract
- No abstract available.
- Subjects :
- Oncology
Male
Cancer Research
Chromosomes, Human, Pair 22
bcr-abl
Messenger
Fusion Proteins, bcr-abl
Translocation, Genetic
80 and over
Favorable outcome
RNA, Neoplasm
Chronic
Aged, 80 and over
Leukemia
Follow up studies
Myeloid leukemia
molecular response
Hematology
General Medicine
Middle Aged
Survival Rate
outcome
Female
Chromosomes, Human, Pair 9
medicine.drug
Human
Pair 9
Adult
medicine.medical_specialty
Disease free survival
transcript type
MEDLINE
Translocation
Disease-Free Survival
Chromosomes
Follow-Up Studie
Text mining
Genetic
chronic myeloid leukemia
Internal medicine
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
medicine
Humans
RNA, Messenger
Survival rate
nilotinib
Aged
Follow-Up Studies
Pyrimidines
business.industry
chronic myeloid leukemia, nilotinib, transcript type, molecular response, outcome
Fusion Proteins
Nilotinib
Pyrimidine
RNA
Neoplasm
BCR-ABL Positive
Pair 22
business
Myelogenous
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....955bdbedede7910abffefc245f430004